Table 1.
Characteristics of included patients (n = 653) and contribution of countries
| N | Value | |
|---|---|---|
| Age, years | 649 | |
| Mean ± SD (range) | 63.3 ± 16.0 (18–90) | |
| Median (IQR) | 66 (54–76) | |
| Sex, male/female | 649 | 380 (58.6%) / 269 (41.4%) |
| Body mass index, kg/m2 | 535 | |
| Mean ± SD | 27.8 ± 5.6 | |
| Median (IQR) | 27.0 (24.0–30.6) | |
| Primary indication for ICM | 649 | |
| Syncope or presyncope | 371 (57.2%) | |
| Cryptogenic stroke | 163 (25.1%) | |
| Management of atrial fibrillation | 46 (7.1%) | |
| Other | 69 (10.6%) | |
| Coronary artery disease | 651 | 111 (17.1%) |
| Hypertension | 651 | 367 (56.4%) |
| History of heart failure | 651 | 76 (11.7%) |
| History of atrial fibrillation | 651 | 115 (17.7%) |
| History of ventricular arrhythmia | 651 | 49 (7.5%) |
| History of stroke / transient ischemic attack | 651 | 184 (28.3%) |
| Diabetes | 651 | 111 (17.1%) |
| Contributing country | 653 | |
| Germany | 188 (28.8%) | |
| France | 132 (20.2%) | |
| Spain | 89 (13.6%) | |
| Australia | 80 (12.3%) | |
| Switzerland | 53 (8.1%) | |
| Italy | 31 (4.7%) | |
| Portugal | 28 (4.3%) | |
| Austria | 22 (3.4%) | |
| Latvia | 19 (2.9%) | |
| Hungary | 8 (1.2%) | |
| Denmark | 3 (0.5%) |
Data are shown as n (%) if not stated otherwise.
ICM = insertable cardiac monitoring; IQR = interquartile range.